High Purity Retatrutide 30mg 99% Research Peptide Lyophilized Powder CAS 2381089-83-2
TDS 7465 Inquiries
2381089-83-2
Research Grade
99%
ShenZhen
XH
10 vials/kit,10mg/vial
Yes
2026-10-23 ~ 2026-12-31
Retatrutide,Tirzepatide,Semaglutide,GHK-CU,NAD+,MOTS-C
-
Product Details
-
Seller Information
-
History Price
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceRetatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.CertificatesBasic Info-
Product Name:
Retatrutide
Other Name:Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide
CAS No.:2381089-83-2
InChIKeys:MLOLQJNKXBNWFW-SAGGEDDASA-N
Molecular Weight:0
EC Number:200-001-8
Color/Form:White lyophilized
Categories:
Characteristics-
Water Solubility:
Soluble in water (5mg/ml).
Storage Conditions:-20°C
Critical Temperature & Pressure:-20°C
Research-
Class:
Triple agonist — GCGR, GIPR, GLP-1R
Status:Investigational (Phase 3)
Mechanism:Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.
EC50 (Human GCGR):5.79 nM
EC50 (Mouse GIPR):0.191 nM
EC50 (Mouse GLP1R):0.794 nM
EC50 (Mouse GCGR):2.32 nM
EC50 (Human GLP1R):0.775 nM
EC50 (Human GIPR):0.0643 nM
Source:Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI
Clinical Development:
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepatide,Semaglutide,GHK-CU,NAD+,MOTS-C
-
Location:
Block 1, No. 205, Tongbao Road, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province (within Zhejiang Juzhiyun Holding Co., Ltd., on the 4th floor of 2 buildings)
-
Payment Terms:
TT against copy of documents,O/A,100% TT in advance
-
Total Employees:
101-200
-
Year of Establishment:
2026
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Inquiry History7465 Inquiries
Country Product Purchase Quantity Date Posted
United States
Tesa
2 MG Oct 25, 2026
Colombia
Retatrutide
15 MG Oct 25, 2026
United States
Retatrutide
10 G Oct 25, 2026
Canada
Retatrutide
1 KG Oct 25, 2026
United Kingdom
Retatrutide
1 G Oct 25, 2026
Netherlands
Retatrutide
10 MG Oct 25, 2026
Australia
Retatrutide
10 MG Oct 25, 2026
Netherlands
Retatrutide
20 MG Oct 25, 2026
Germany
Retatrutide
1 KG Oct 25, 2026
United Kingdom
Retatrutide
10 G Oct 25, 2026
United States
Retatrutide
20 MG Oct 25, 2026
Poland
Retatrutide
20 MG Oct 25, 2026
United States
Retatrutide
10 MT Oct 25, 2026
United States
Retatrutide
300 MG Oct 25, 2026
Germany
Retatrutide
1 MT Oct 24, 2026
Malta
Retatrutide
10 MT Oct 24, 2026
United States
Retatrutide
2000 MG Oct 24, 2026
Australia
Retatrutide
100 MT Oct 24, 2026
Bulgaria
Retatrutide
10 PCS Oct 24, 2026
United States
retatrutide
10 MT Oct 24, 2026 Post an enquiry for this product
More from this Seller
-
-
-
HX5 5mg Factory Direct Supply Wholesale Low-Price Lyophilized Powder Peptide
Pharmaceutical Grade / 99.5%
$45.05/UNIT FOB
-
-
-
-
LL-37 LL-37, LL37 peptide, Cathelicidin LL-37, Antimicrobial peptide, Human cathelicidin peptide, Synthetic LL-37, Bioactive peptide, Immunomodulator
Pharmaceutical Grade / 99%
$9.7/G FOB
-
-
-
-
High Purity Semaglutide 40mg Research Peptide High Purty Lyophilized Powder CAS 910463-68-2
Research Grade / 99%
$9.8/UNIT FOB
-
-
-
-
High purty Cardiogen 99% Freeze-dried powder CA In stock Minimum Order
Research Grade / 99.89%
$9.9/UNIT FOB
-
-
-
-
Research-Grade IGF-1 DES Truncated Polypeptide Powder
High Purity Grade / 99.9%
$45.05/G FOB
-
-
-
-
HMG powder High purity HMG Pharmaceutical grade API Bulk peptide powder Lyophilized peptide HMG vial 75IU HMG Fertility peptide Synthetic
Pharmaceutical Grade / 99%
$9.9/MT FOB
-
